|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
R310 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.07%
|
20.70%
|
9.69%
|
4.91%
|
2.77%
|
1.80%
|
1.19%
|
0.87%
|
0.63%
|
0.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R31.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
87086
|
URINE CULTURE/COLONY COUNT |
37,065
|
37,140
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
30,214
|
30,360
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
30,177
|
30,352
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
28,869
|
2,931,056
|
|
74178
|
CT ABD&PLV WO CNTR FLWD CNTR |
28,455
|
28,457
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
22,717
|
22,821
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
22,021
|
22,061
|
|
80048
|
METABOLIC PANEL TOTAL CA |
17,039
|
17,070
|
|
82565
|
ASSAY OF CREATININE |
14,392
|
14,401
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
13,963
|
14,182
|
|
80053
|
COMPREHEN METABOLIC PANEL |
13,624
|
13,627
|
|
52000
|
CYSTOURETHROSCOPY |
12,119
|
12,120
|
|
81003
|
URINALYSIS AUTO W/O SCOPE |
11,473
|
11,513
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
10,614
|
11,645
|
|
85610
|
PROTHROMBIN TIME |
9,835
|
9,872
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
9,662
|
27,423
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
9,473
|
10,588
|
|
74176
|
CT ABD & PELVIS W/O CONTRAST |
9,381
|
9,381
|
|
G1004
|
CDSM NDSC |
9,102
|
10,958
|
|
87088
|
URINE BACTERIA CULTURE |
7,275
|
7,475
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R31.0 related to the following DRG Codes:
695-696
791
793
|
